Conversely, net sales decreased to $851.6 million for the full-year 2020, compared to $893.9 million in 2019.
The decrease was largely due to lower volume-related to the COVID-19 pandemic in 2Q and 3Q.
were closed in compliance with government orders in late March.
However, volume increased significantly in June across all product lines and net sales in July through October exceeded prior year on a consolidated basis.
We reported net income of $22.2 million or $0.68 per diluted share for the three months ended October 31, 2020, compared to a net loss of $30.9 million or $0.94 per diluted share during the three months ended October 31, 2019.
For fiscal 2020, we reported net income of $38.5 million or $1.17 per diluted share, compared to a net loss of $46.7 million or $1.42 per diluted share for fiscal 2019.
For the full-year 2020, adjusted EBITDA increased by almost 2% to $104.5 million, compared to $102.7 million in 2019.
The increase in earnings for the three months ended October 31, 2020, were mainly due to higher volumes, improved operating leverage and lower raw material costs.
